Multicenter study into the effects of long-term physiotherapy rehabilitation in COPD (GOLD (III-IV) on drug therapy and hospitalizations
A total of 21 physiotherapy practices in The Netherlands were definitively included by research group from Physical Therapy & Science Association, in the study. They provided retrospectively (2018) research data from 402 patients with severe to very severe COPD (â™‚ 207, â™€ 193). In 2018, this cohort was offered first-line physiotherapy rehabilitation with an average frequency of twice a week. In 2018, this led to an average of 2.3 exacerbations and 0.4 hospitalizations (duration μ 10.7 days) per year.
The drug therapy for a exacerbation led to prescription of antibiotics (μ 1.6 per year) and prednisolone (μ 1.7 per year). Within the cohort the general practitioner or lung physician prescribed the long-term use of antibiotics (6%) and prednisolone (3%).
This cohort study will be continued in 2019 to investigate the effects of reducing the frequency of physiotherapy rehabilitation on medication use and hospitalizations.
Drs. D. Postel, Mw. drs. S. Werner, Drs. C. Freriks, Mw. Drs. M. Willekens, Dr. N. Hutting, Drs. D.M. Keesenberg Physical Therapy & Science Association